Search

BOSTON: Revitope Oncology, Inc. has issued the following news release: Revitope Oncology Inc. (Revitope), a biotechnology company advancing a new class of precision cancer immunotherapies, announced today that it has [...]

ROCKVILLE: MaxCyte, Inc., a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing applications, and Kamau Therapeutics, [...]

BEIJING: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. has issued the following news release: Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotech company focusing on the discovery of novel [...]

NANJING: Triastek Inc. (Triastek), a global leader in 3D printing pharmaceuticals, announced that it has entered into a research collaboration and platform technology license agreement with BioNTech SE (BioNTech), a [...]

WEST SACRAMENTO: Nufarm has issued the following news release: Yield10 Bioscience, Inc. (OTC:YTEN) ('Yield10' or the 'Company'), an agricultural bioscience company, announced that the Company has signed a Memorandum of [...]

WOBURN: Yield10 Bioscience, Inc. (OTC:YTEN) (Yield10 or the Company), an agricultural bioscience company, today announced that the Company has signed a Memorandum of Understanding (MOU) and License Agreement with Nuseed [...]

WEST SACRAMENTO: Yield10 Bioscience, Inc. announced that the Company has signed a Memorandum of Understanding and License Agreement with Nuseed Nutritional US Inc. granting Nufarm a commercial license to certain [...]

PARIS: Ipsen announced confirmation of an expanded collaboration and license agreement with Exelixis, Inc. for the development of Cabometyx(r) (cabozantinib) in advanced pancreatic neuroendocrine tumors (pNETs) and advanced extra-pancreatic neuroendocrine [...]

PISCATAWAY: KASHIV BIOSCIENCES, LLC has issued the following news release: Kashiv BioSciences, LLC ('Kashiv' or the 'Company') today announced that it has entered into an exclusive licensing agreement for ADL018, [...]

EL CAJON: PURE Bioscience, Inc. and AgroVet Alliance, FZE enter into a multi-year international supply and license agreement for the purchase and selling of SDC products under special terms and [...]

CAMBRIDGE: Nona Biosciences has issued the following news release: Nona Biosciences, a global biotechnology company providing a total solution from 'Idea to IND' (I to ITM), ranging from target validation [...]

London: MaxCyte Inc has issued the following press release: MaxCyte Inc - Rockville, Maryland-based provider of cell engineering platform technologies developing 'next-generation cell therapeutics' - Inks strategic platform license agreement [...]

ALAMEDA: Exelixis, Inc. (Nasdaq: EXEL) announced that it has entered into a Settlement and License Agreement (Agreement) with Cipla Ltd. and Cipla USA, Inc. (collectively Cipla). This settlement resolves two [...]

CAMBRIDGE: Enveric Biosciences, Inc, announces that it has signed a non-binding term sheet with an undisclosed biotechnology development and commercialization company to exclusively out-license two patent families of Methods for [...]

Shares of Enveric Biosciences ENVB traded higher after the company signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical [...]

SOUTH SAN FRANCISCO: Allogene Therapeutics, Inc. and Arbor Biotechnologies, Inc. announce a non-exclusive, global gene editing licensing agreement for the use of Arbor's proprietary CRISPR gene-editing technology in Allogene's next-generation [...]

Chicago: Sidley Austin has issued the following press release: Sidley represented Sagard Healthcare in purchasing a 1% royalty in net sales of Tyvaso DPI(r) (treprostinil) inhalation powder from MannKind Corporation [...]

ROCKVILLE: MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing [...]

South San Francisco: GenEdit, Inc., a developer of genetic medicines that leverage its NanoGalaxy(r) platform for tissue-selective delivery, announced a multiyear collaboration and license agreement with Genentech, a member of [...]

ROCKVILLE: MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell-based therapeutics and innovative bioprocessing [...]

DUBLIN: ERS Genomics Limited has announced a non-exclusive CRISPR/Cas9 license agreement with StemSight Oy, a biotechnology company developing stem cell-based therapies for corneal blindness. The agreement grants StemSight access to [...]

Paris: Biocodex, a French pharmaceutical group, has signed a licensing agreement with Belgian biotech company My Health to market the DUOSPORE(r) dietary supplement in several countries. My Health, founded in [...]

DURHAM: PRECISION BIOSCIENCES, INC. has issued the following news release: Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS(r) platform to develop in vivo [...]

Mechelen: Galapagos NV (Euronext & NASDAQ: GLPG) today announced that it has entered into a strategic collaboration and licensing agreement with BridGene Biosciences, Inc. ('Bridgene'), a biotechnology company that uses [...]

WESTLAKE VILLAGE: MannKind Corporation announced that on December 27, 2023 it sold a 1% royalty in net sales of Tyvaso DPI(r) (treprostinil) inhalation powder in exchange for up to $200 [...]

SAN DIEGO: Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced it has entered into a royalty-backed financing agreement that provides Dare with $5 million at [...]

HOLON: Compugen Ltd has issued the following news release: Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN) a clinical-stage cancer immunotherapy company and a pioneer in computational target discovery, today announced that [...]

FOSTER CITY: Gilead Sciences, Inc has issued the following news release: Gilead Sciences, Inc. (Nasdaq: GILD) today announced an agreement with Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer [...]

CAMBRIDGE: Nona Biosciences has issued the following news release: Nona Biosciences, a global biotechnology company providing a total solution from 'Idea to IND' (I to ITM), ranging from target validation [...]

CAMBRIDGE: Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome editing company, today announced that the Company and Vertex Pharmaceuticals entered into a license agreement. Under terms of the agreement, Vertex [...]

DUBLIN: Research and Markets has issued the following news release: The 'Licensing Deals in Biotechnology 2019-2023' report has been added to ResearchAndMarkets.com's offering. The report on Licensing Deals in Biotechnology [...]

SAN DIEGO: Skye Bioscience, Inc. (Skye), a pharmaceutical company developing drugs targeting the endocannabinoid system, and Tautomer Bioscience (Pty) Limited (Tautomer), a privately-owned biopharmaceutical company focused on addressing unmet medical [...]

SOMERSET: Legend Biotech Corporation (Legend Biotech), a global biotechnology company developing, manufacturing and commercializing novel therapies to treat life-threatening diseases, announced that Legend Biotech Ireland Limited, a wholly owned subsidiary [...]

Tokyo, Japan and Cambridge: Sosei Group Corporation has issued the following news release: Sosei Group Corporation ('Sosei Heptares' or 'the Company'; TSE: 4565) will receive a US$3.75 million milestone payment [...]

DUBLIN: ERS Genomics has issued the following news release: ERS Genomics, co-founded by Dr. Emmanuelle Charpentier, a recipient of the 2020 Nobel Prize in Chemistry for her pioneering work on [...]

SAN DIEGO: Hummingbird Bioscience ('Hummingbird Bio') a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, and Endeavor BioMedicines ('Endeavor'), a clinical-stage company targeting the drivers [...]

SAN DIEGO: Dare Bioscience, Inc. (NASDAQ: DARE), a leader in women's health innovation, today announced the first shipment of XACIATOTM [pronounced zah-she-AH-toe] (clindamycin phosphate) vaginal gel, 2% in connection with [...]

PISCATAWAY: KASHIV BIOSCIENCES LLC has issued the following news release: Kashiv Biosciences LLC ('Kashiv'), a fully integrated biopharmaceutical company, and Alvotech (NASDAQ: ALVO), a global biotech company specializing in the [...]

Helsinki: Alvotech S.A. has issued the following news release: Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide and Kashiv [...]

SHANGHAI: Everest Medicines has issued the following news release: Everest Medicines (HKEX 1952.HK, 'Everest', or the 'Company'), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines [...]

DUBLIN: ERS Genomics Limited (ERS) announced a new license agreement with Santa Cruz Biotechnology Inc (SCBT). This is a non-exclusive licensing agreement granting SCBT access to the ERS CRISPR/Cas9 patent [...]

ZHUHAI: Biotheus has issued the following news release: Biotheus Inc. ('Biotheus'), a clinical-stage biotech company dedicated to the discovery and development of biologics for oncology and inflammatory diseases, announced today [...]

Shares of Acadia Pharmaceuticals Inc. ACAD traded higher on Friday after the company expanded its existing trofinetide licensing agreement with Neuren Pharmaceuticals to acquire ex-North American rights to the drug. [...]

ROCKVILLE, Md: MaxCyte, Inc has issued the following news release: MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development [...]

BEIJING: Brii Biosciences Limited (Brii Bio, we, or the Company, stock code: 2137.HK), a biotechnology company developing therapies to improve patient health and choice across diseases with high unmet needs, [...]

NEW YORK: Terran Biosciences, Inc. (Terran), a CNS-focused biotech platform company, has entered into an agreement with French pharmaceutical company Pierre Fabre Medicament S.A.S (Pierre Fabre) for worldwide exclusive rights [...]

DUBLIN: ERS Genomics has issued the following news release: ERS Genomics Limited ('ERS') is pleased to announce a new license agreement with Applied Biological Materials Inc ('abm,'). This is a [...]

SAN DIEGO: NIELSEN BIOSCIENCES, INC has issued the following news release: Nielsen BioSciences, Inc. ('Nielsen'), a privately-held, San Diego-based biopharmaceutical company, today announced that it has entered into a license [...]

Stockholm: Alligator Bioscience AB has issued the following news release: Alligator Bioscience (Nasdaq Stockholm: ATORX) today announces that Orion Corporation, a global pharmaceutical company based in Finland, has selected bispecific [...]

Dublin: Research and Markets has issued the following news release: The 'JAK inhibitors - Competitive Landscape, 2023' report has been added to ResearchAndMarkets.com's offering. This 'JAK inhibitors - Competitive landscape, [...]